Definitions

As used in this subchapter: (1) "Board" means the State Board of Finance; (2) "Choosing Wisely initiative" means the initiative established by the American Board of Internal Medicine Foundation that seeks to advance a national dialogue on avoiding wasteful or unnecessary medical tests, treatments, and procedures; (3) "Emerging therapies" means therapeutic services that have not historically been covered but for which new evidence may demonstrate therapeutic enhancements or opportunities for cost avoidance, or both; (4) "Evidence" means peer-reviewed objective studies of emerging therapies; and (5) "Regenerative injection therapy" means a nonsurgical orthopedic treatment performed by injecting into a joint or soft tissue a substance that stimulates the growth of normal cells and tissues for the purpose of strengthening or repairing a painful or injured joint or connective tissue. Amended by Act 2021, No. 1004,§ 23, eff. 4/28/2021. Added by Act 2017, No. 1089,§ 2, eff. 8/1/2017. As used in this subchapter: (1) "Board" means the State Board of Finance; (2) "Choosing Wisely initiative" means the initiative established by the American Board of Internal Medicine Foundation that seeks to advance a national dialogue on avoiding wasteful or unnecessary medical tests, treatments, and procedures; (3) "Emerging therapies" means therapeutic services that have not historically been covered but for which new evidence may demonstrate therapeutic enhancements or opportunities for cost avoidance, or both; (4) "Evidence" means peer-reviewed objective studies of emerging therapies; and (5) "Regenerative injection therapy" means a nonsurgical orthopedic treatment performed by injecting into a joint or soft tissue a substance that stimulates the growth of normal cells and tissues for the purpose of strengthening or repairing a painful or injured joint or connective tissue. Amended by Act 2021, No. 1004,§ 23, eff. 4/28/2021. Added by Act 2017, No. 1089,§ 2, eff. 8/1/2017.